Innovative synthetic chimeric viruses, such as vesiculovirus, incorporating Morreton virus glycoprotein with VSV genes, have shown promising safety and immunogenicity profiles in Ewing sarcoma and fibrosarcoma models, inducing potent CD8+ T-cell responses and tumor regression (91). This evidence concerns the gene CD8A and neoplasm.